Promore Pharma AB 

€0.000000
0
+€0.00+0% 00:00 Hari ini

Statistik

Tertinggi harian
-
Paras terendah hari ini
-
Tertinggi 52M
-
Paras terendah 52M
-
Volum
-
Vol. purata
-
Kap. pasaran
0
Nisbah P/E
-
Hasil dividen
-
Dividen
-

Orang juga ikut

Senarai ini berdasarkan senarai pantauan pengguna Stock Events yang mengikuti 8T0.STU. Ia bukan cadangan pelaburan.

Pesaing

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ia bukan cadangan pelaburan.

Perihal

Promore Pharma AB (publ), a biopharmaceutical company, develops peptide-based drug candidates in Sweden and internationally. Its product candidates include PXL01 that is in Phase IIa study for the prevention of post-surgical adhesions and scars, and for the prevention of dermal scars, as well as for tendon repair surgery in the hand; and LL-37, which has completed Phase IIb clinical studies for treating patients with venous leg ulcers, stimulate the healing of chronic wounds, and for the treatment of diabetic foot ulcers. The company was formerly known as Lipopeptide AB and changed its name to Promore Pharma AB (publ) in January 2017. Promore Pharma AB (publ) was founded in 2002 and is headquartered in Solna, Sweden.
Show more...
CEO
Dr. Jonas Ekblom Ph.D.
Pekerja
1
Negara
Sweden
ISIN
SE0009947740

Penyenaraian

0 Comments

Kongsi pendapat anda

FAQ

Apakah simbol saham Promore Pharma AB?
Bergantung pada bursa, simbol saham mungkin berbeza. Sebagai contoh, di bursa Boerse Stuttgart, saham Promore Pharma AB didagangkan di bawah simbol 8T0.STU.
Berapa ramai pekerja yang dimiliki oleh Promore Pharma AB?
Sehingga Julai 10, 2026, syarikat mempunyai 1 pekerja.
Promore Pharma AB terletak dalam sektor apa?
Promore Pharma AB beroperasi dalam sektor Kesihatan & Kesejahteraan.
Bilakah Promore Pharma AB menyiapkan split saham?
Promore Pharma AB tidak mempunyai sebarang split baru-baru ini.
Di manakah ibu pejabat Promore Pharma AB?
Ibu pejabat Promore Pharma AB terletak di Solna, Sweden.